Cheng et al. suggested that elevated serum hS-CRP and HCY levels were associated with the risk of PSD 1 year after stroke, and this was likely to be a factor influencing the favorable outcomes at 90 days [32]. The gene discussed is CRP; the disease is stroke disorder.